Advanced HR+/HER2- breast cancer

Clinical trials for Advanced HR+/HER2- breast cancer explained in plain language.

Never miss a new study

Get alerted when new Advanced HR+/HER2- breast cancer trials appear

Sign up with your email to follow new studies for Advanced HR+/HER2- breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 4 Not yet recruiting 2 Not yet finished but already full! 1 Completed 1

Can Anti-Diarrhea meds make a powerful breast cancer drug safer?

Disease control Completed

This phase 2 trial tested whether adding loperamide (Imodium) and a white blood cell booster (G-CSF) could reduce severe diarrhea and low white blood cell counts caused by the drug Trodelvy in people with advanced breast cancer. Fifty patients with metastatic triple-negative or l…

Matched conditions: ADVANCED HR+/HER2- BREAST CANCER

Phase 2 • Sponsor: MedSIR • Aim: Disease control

Last updated Jun 27, 2026 08:01 UTC

Advanced HR+/HER2- breast cancer

Get alerted when new Advanced HR+/HER2- breast cancer trials appear

Can Anti-Diarrhea meds make a powerful breast cancer drug safer?